Sudarshan Pharma Industries Ltd IPO
i. Sudarshan Pharma core business is Specialty Chemicals & Intermediates for Pharma, agro chemicals, Coating, paints, adhesive and various other industries. They are also into Active Pharmaceuticals Ingredients manufacturing. Some products they outsource and manufacturer at its toll manufacturing facility, they are also into specialty chemicals imports & exports as well as supply of same to the actual users. As per the clients need and requirements, they provide customize specialty chemicals to its clients in India and abroad regularly.
ii. They are also involved in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
iii. They carry about Ethical marketing of pharmaceutical formulation & products in the Domestic and International market through its own distribution network and Sales force under its own brands.
iv. The Company & its executives have developed the skill and expertise in innovation in specialty chemical, bulk drugs, API and pharmaceutical formulation to provide the products having wide application in pharma, agro chemicals, performance chemicals, resins, paint, food, adhesive and various other Industries. They also offer services of QC and Formulation Development to provide customised solutions to its customers and assist them in sourcing the innovative products as per their needs.
v. Presently, the company has a Contract Manufacturing Agreement with few pharmaceutical companies. The company has also joined hands with regular suppliers having FDA and WHO approved plant along with its own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for its own brands.
vi. They have launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and many more as well as have established goodwill for quality products and have regular clients for the same.
vii. The company operate both in domestic and international markets. Presently, they are supplying Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets.
viii. The Management is planning for business expansion by having its own state of the art manufacturing facility at Mahad along with its mini manufacturing facility at Wada Area, Formulation GMP unit at Tarapur, Maharashtra. It also plans to develop distributor network & logistic facility in Mumbai, Delhi, Chennai, Hyderabad and Ahmedabad. This shall also support E-commerce and Online marketing of the company‘s products.
i. Experienced Promoters and Management Team
ii. Scalable Business Model
iii. Wide and diverse range of product offerings
Objects of the Sudarshan Pharma Industries Ltd IPO:
Sudarshan Pharma Industries Ltd IPO Details:
|Open Date:||Mar 09 2023|
|Close Date:||Mar 14 2023|
|Face Value:||₹ 10 Per Equity Share|
|Issue Type:||Book Built Issue IPO|
|Issue Size:||50.10 Cr.|
|Lot Size:||1600 Shares|
|Issue Price:||₹ 71-73 Per Equity Share|
|Listing At:||BSE SME|
|Listing Date:||Mar 22 2023|
Promoters And Management:
Financials of Sudarshan Pharma Industries Ltd IPO:
|Particulars ( In Crore )||6MFY23||2022||2021||2020|
|Revenue from Operations||195||357||193||147|
|Cost of Materials Consumed||187||360||185||144|
|Change in Inventories||-2||-22||-6||-6|
|Employee Benefits Expense||1||2||1||1|
|Depreciation & Amortisation||0.43||0.86||0.74||0.34|
Comparison With Peers:
|Name of the Company||Revenue (Cr)||Profit (Cr)||P/E||EPS||CMP||Mcap (Cr)|
|Sudarshan Pharma Industries Limited||390||7||24.35||2.99||73||175|
|ERIS Lifesciences Limited||1,588||393||21.6||29.21||624||8,487|
|Sigachi Industries Limited||285||43||18.30||13.84||253||778|
|Aarti Drugs Limited||2,443||153||22.1||16.48||364||3,370|